Form 15-12G - Securities registration termination [Section 12(g)]
January 04 2024 - 1:21PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-36003
Histogen Inc.
(Exact
name of registrant as specified in its charter)
Address Not
Applicable11
(302) 636-5401
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock, $0.0001 par value per share
(Title of each class of securities covered by this Form)
None
(Titles of all other
classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es)
to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
| Rule 12g-4(a)(1) |
|
☒ |
| Rule 12g-4(a)(2) |
|
☐ |
| Rule 12h-3(b)(1)(i) |
|
☒ |
| Rule 12h-3(b)(1)(ii) |
|
☐ |
| Rule 15d-6 |
|
☐ |
| Rule 15d-22(b) |
|
☐ |
Approximate number of holders of record as of the certification or notice date: 101.
Pursuant to the requirements of the Securities Exchange Act of 1934, Histogen Inc. has caused this certification/notice to be signed on its behalf by the
undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
|
|
Histogen Inc. |
|
|
|
|
| Date: |
|
January 4, 2024 |
|
By: |
|
/s/ Susan A. Knudson |
|
|
|
|
|
|
Susan A. Knudson |
|
|
|
|
|
|
Chief Executive Officer, President, Chief Financial Officer and Secretary |
| 1 |
Histogen Inc. (the “Company”) terminated its lease agreement for its headquarters and laboratory.
Accordingly, the Company does not maintain a headquarters. For purposes of compliance with applicable requirements of the Securities Act of 1933, as amended, and Securities Exchange Act of 1934, as amended, any stockholder communication required to
be sent to the Company’s principal executive offices may be directed to the Company’s agent for service of process at Corporation Service Company, 251 Little Falls Drive, Wilmington, New Castle County, Delaware 19808, or to the email
address set forth in the Company’s proxy materials and/or identified on the Company’s investor relations website. |
Histogen (NASDAQ:HSTO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Histogen (NASDAQ:HSTO)
Historical Stock Chart
From Apr 2023 to Apr 2024
